国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

The Gold Standard Drug Database: Your Prescription for Accurate Healthcare

Gauri Rao

The Gold Standard Drug Database (GSDD) represents a pivotal advancement in healthcare, offering a comprehensive and reliable resource for healthcare professionals, researchers, and patients. This abstract provides an overview of GSDD's significance, outlining its key features, and the transformative impact it has on the healthcare industry. In today's complex and rapidly evolving healthcare landscape, the accurate and up-to-date information on pharmaceuticals is paramount for effective patient care, drug research, and decision-making. The Gold Standard Drug Database stands as a trusted, industry-standard resource for drug information. This comprehensive database encompasses a vast array of pharmaceutical data, ensuring that healthcare providers, researchers, and individuals have access to the most accurate and current information on medications. Furthermore, GSDD facilitates pharmaceutical research by offering comprehensive data for studies and clinical trials. Researchers benefit from the database's reliability and accuracy, saving time and resources that might otherwise be spent on data collection and validation